A positive correlation between pralatrexate sensitivity and mRNA expression of FPGS, a major enzyme responsible for polyglutamation of antifolates, was found in the 15 cancer cell lines, suggesting an important role of polyglutamation in cellular response to pralatrexate. This evidence concerns the gene FPGS and cancer.